Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

What is the patent landscape for Budesonide, and when can generic versions of Budesonide launch?

Budesonide is a drug marketed by Apotex Inc, Impax Labs Inc, Mylan, Teva Pharms, Mayne Pharma, Alvogen Malta, Zydus Pharms Usa Inc, Teva Pharms Usa, Sandoz Inc, Appco Pharma Llc, and Barr Labs Div Teva. and is included in twelve NDAs.

The generic ingredient in BUDESONIDE is budesonide. There are twenty drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the budesonide profile page.

Summary for Tradename: BUDESONIDE

Suppliers / Packagers: see list26
Bulk Api Vendors: see list93
Clinical Trials: see list100
Patent Applications: see list8,186
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BUDESONIDE at DailyMed

Pharmacology for Tradename: BUDESONIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc
SUSPENSION;INHALATION078202-001Mar 30, 2009ANRXNoNo► Subscribe► Subscribe
Teva Pharms
SUSPENSION;INHALATION077519-002Nov 18, 2008ANRXNoNo► Subscribe► Subscribe
Impax Labs Inc
SUSPENSION;INHALATION078404-002Jul 31, 2012ANRXNoNo► Subscribe► Subscribe
Apotex Inc
SPRAY, METERED;NASAL078949-002Nov 20, 2015OTCNoNo► Subscribe► Subscribe
Mayne Pharma
CAPSULE;ORAL206623-001Apr 8, 2016ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Formulary management
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus